Jump to content

David Argyle

From Wikipedia, the free encyclopedia

David Argyle BVMS DECVIM-CA (Oncology) FRSE FRSA FRCVS is Head of the College of Medicine and Veterinary Medicine at the University of Edinburgh.[1]

Argyle specialises in comparative oncology and cancer in animals. Recognised as an RCVS Specialist in Veterinary Oncology, Argyle was also awarded foundation Diplomat status in Veterinary Oncology in 2005 in recognition for his standing and contributions to the discipline.[2] He later established the Riddell Swann Cancer Centre at Easter Bush, now considered a model for comprehensive cancer therapy and a training ground for the next generation of clinical oncologists.[3] Argyle is Head of the examining board for the European Diploma Qualification in Oncology,[4] chair of the examination board for the ECVIM residency programme for Oncology,[5] and has trained a number of clinical oncologists now in private practice or clinical roles. In 2016 he was elected Fellow of the Royal Society of Edinburgh, and in the same year Fellow of the Royal College of Veterinary Surgeons (for meritorious contributions to veterinary research).[6] As Dean of Veterinary Medicine at the University of Edinburgh, he has successfully introduced a new career pathway for veterinarians to enable both research and clinical training through the Wellcome Trust Funded “Edinburgh Clinical Academic track for Veterinarians” (ECAT-V).[7]  

In 2008, Argyle was awarded the Petplan Prize for Scientific Achievement and in 2014, the Kennel Club International Award for contributions to canine health.[7]

Veterinary career

[edit]

Controversy

[edit]

In 2019 the Sunday Times published two articles alleging a 'toxic' culture at the Dick Vet school in Edinburgh, of which Argyle is Head. In 2020, an independent review (Intersol Global Report) was commissioned by the University of Edinburgh. The summary of the Intersol report was leaked to the national and veterinary press (Sunday Times[13] and The Veterinary Record [14][15]), leading the RCVS to warn against 'Trial by media'. The allegations were rejected by an independent investigation, which concluded there was no evidence of misconduct. This conclusion was upheld after an appeal.[16]

On 5 November 2020, Argyle temporarily stepped down from his Junior Vice President and RCVS Council duties for personal reasons.[17]

Publications

[edit]

Books and Chapters

[edit]
  • Decision Making in Small Animal Oncology (2009)[18]
  • Advances in cancer diagnostics (2008)[19]
  • Decision making in feline cancer patients (2008)[20]
  • What is new in canine and feline lymphoma (2008)[21]
  • Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment (2019)[22]

References

[edit]
  1. ^ a b "Professor David Argyle". The University of Edinburgh. 1 March 2023. Retrieved 2 June 2023.
  2. ^ "Type - Professionals". www.rcvs.org.uk. Retrieved 26 October 2020.
  3. ^ Limited, BMJ Publishing Group (22 December 2012). "New head of clinical oncology for Edinburgh cancer centre". Veterinary Record. 171 (25): 636. doi:10.1136/vr.e8544. ISSN 0042-4900. PMID 23264376. S2CID 12512888. Archived from the original on 30 October 2020. Retrieved 26 October 2020. {{cite journal}}: |last= has generic name (help)
  4. ^ "Prof David Argyle - EBVS - European Board of Veterinary Specialists". ebvs.eu. Retrieved 26 October 2020.
  5. ^ Medicine, David Argyle | Dean of Veterinary; Edinburgh, Head of School University of (26 October 2020). "David Argyle | The Vet Expo". The Vet Expo 2020. Retrieved 26 October 2020.
  6. ^ "Prof David Argyle". The University of Edinburgh. Retrieved 26 October 2020.
  7. ^ a b "Head of School wins prestigious veterinary award". The University of Edinburgh. Retrieved 26 October 2020.
  8. ^ "Prof David Argyle". The University of Edinburgh. Retrieved 24 May 2020.
  9. ^ "David Argyle - Edinburgh Research Explorer". www.research.ed.ac.uk.
  10. ^ "Professor David John Argyle FRSE". The Royal Society of Edinburgh. 24 March 2020. Retrieved 24 May 2020.
  11. ^ "Prof David Argyle – Roslin Technologies". Retrieved 24 May 2020.
  12. ^ "Professor David Argyle elected RCVS Junior Vice-President for 2020-21". The Royal College of Veterinary Surgeons. Retrieved 17 October 2020.
  13. ^ MacAskill, Mark. "Top vet Professor David Argyle at centre of bullying claims at Edinburgh University".
  14. ^ Waters, Adele (2020). "'Bullying and harassment' at Edinburgh". Veterinary Record. 187 (8): 294–295. doi:10.1136/vr.m3998. PMID 33060213. S2CID 222412486.
  15. ^ Waters, Adele (2020). "Edinburgh uni should publish full report". Veterinary Record. 187 (8): 289. doi:10.1136/vr.m3991. PMID 33060205. S2CID 222412316.
  16. ^ Frost, Sara (23 October 2020). "No trial by media for next college president – RCVS". Vet Times. Retrieved 26 October 2020.
  17. ^ "Statement concerning RCVS Junior Vice-President Professor David Argyle". rcvs.org.uk. 5 November 2020.
  18. ^ "Decision Making in Small Animal Oncology David Argyle - Google Search". www.google.com. Retrieved 26 October 2020.
  19. ^ Argyle, D. J. (2008). "Advances in cancer diagnostics". Proceedings of the 33rd World Small Animal Veterinary Association Congress. Australian Small Animal Veterinary Association.
  20. ^ Argyle, D. J. (2008). "Decision making in feline cancer patients". Advances in Cancer Diagnostics.
  21. ^ Argyle, D. J. (2008). "What is new in canine and feline lymphoma". Advances in Cancer Diagnostics: 518–520.
  22. ^ Ward, Carol; Meehan, James; Gray, Mark; Kunkler, Ian; Langdon, Simon; Murray, Alan; Argyle, David (12 March 2019). "Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment". Current Topics in Microbiology and Immunology. 430: 225–246. doi:10.1007/82_2019_159. hdl:20.500.11820/006e1e3d-8015-4e24-8537-328f53e1616a. ISBN 978-3-030-62451-4. PMID 30859401. S2CID 75137308.